Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen
This study has been completed.
Study NCT00135369
Information provided by Bristol-Myers Squibb
First Received on August 25, 2005.
Last Updated on April 8, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
